SCHEMBL13384629

SCHEMBL13384629

C=C(OC)c1ccc2c(c1)C(c1ccccc1SC)=CCC2

nearest known ligand 0.34

Predicted protein targets (top 5)

geneUniProtsupporting neighboursconfidence
▸ IDO1 P14902 1/20 0.32
▸ NPC1 O15118 1/20 0.31
▸ GAA P10253 1/20 0.30
▸ RAB9A P51151 1/20 0.30
▸ SMN1; SMN2 Q16637 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2260452 0.86 SMN1; SMN2 (0.42) GAARAB9ASMN1; SMN2
SCHEMBL13384523 0.81 MAPT (0.37) NPC1GAARAB9ASMN1; SMN2
SCHEMBL13384661 0.77 MAOA (0.34) —
SCHEMBL12389316 0.76 HTR2B (0.49) —
SCHEMBL13384464 0.76 CHEK2 (0.33) —
SCHEMBL13384439 0.75 POLQ (0.32) —
SCHEMBL13384645 0.72 HSP90AA1 (0.33) RAB9ASMN1; SMN2
SCHEMBL12365069 0.70 PDK2 (0.43) GAASMN1; SMN2
SCHEMBL12364981 0.70 PDK2 (0.43) NPC1RAB9A
SCHEMBL12364995 0.69 PDK2 (0.45) NPC1RAB9ASMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2177505-A1 BICYCLIC ACYLGUANIDINE DERIVATIVE Astellas Pharma Inc. (JP) 2010-04-21 — — EP disclosed
Send feedback